Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > Insider Trading
Insider Trading      
 
 
Insider NameTransaction DateBuy QuantitySell Quantity% Buy/SellNo of Shares Hold% HoldingsProcessDate
Glenmark Pharmaceuticals Ltd11-Jul-2024 9609571   7/15/2024 12:00:00 AM
Glenn Mario Saldanha11-Jul-2024 7800   7/15/2024 12:00:00 AM
Nirma Ltd12-Mar-202424505435 2091896285753/13/2024 12:00:00 AM
Glenmark Pharmaceuticals Ltd12-Mar-2024 245054352096095717.843/13/2024 12:00:00 AM
Glenmark Pharmaceuticals Ltd06-Mar-2024 67389944553411500627.843/7/2024 12:00:00 AM
GLENN SALDANHA16-Nov-20217505  7800 11/17/2021 12:00:00 AM
GLENN SALDANHA15-Nov-2021295  295 11/17/2021 12:00:00 AM
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.